Biodexa Pharmaceuticals Plc Stock Analysis & AI Score
Biodexa Pharmaceuticals Plc (BDRX) has an ST Score of 32.8 (C-), driven by its Growth (B) and held back by its Momentum (D-). BDRX last traded at $0.68.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Biodexa Pharmaceuticals Plc (BDRX) has an ST Score of 32.8 (C-), driven by its Growth (B) and held back by its Momentum (D-). BDRX last traded at $0.68.
- Strongest
- GrowthB
- Weakest
- MomentumD-
All factor grades
- GrowthB
- ValuationC
- ProfitabilityC
- Financial StrengthC
- MomentumD-
- Piotroski1/9
Contact
BDRX stock: frequently asked questions
What is BDRX's ST Score?
Biodexa Pharmaceuticals Plc (BDRX) has an ST Score of 32.8 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BDRX a buy, hold, or sell?
Our ST Score grades it C- (32.8/100). The ST Score is a data-driven signal, not a recommendation.
What are BDRX's factor grades?
Valuation C, Profitability C, Financial Strength C, Momentum D-, Growth B.
What is BDRX's valuation grade?
Biodexa Pharmaceuticals Plc (BDRX) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BDRX's growth grade?
Biodexa Pharmaceuticals Plc (BDRX) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BDRX's profitability grade?
Biodexa Pharmaceuticals Plc (BDRX) earns a profitability grade of C, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BDRX's financial strength grade?
Biodexa Pharmaceuticals Plc (BDRX) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is BDRX's Piotroski score?
Biodexa Pharmaceuticals Plc (BDRX) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.